STROBER, B. .; IMAFUKU, S. .; PAUL, C.; GOODERHAM, M.; SPELMAN, L.; SEO, S. J.; PASSERON, T.; HOYT, K.; COLOMBO, M. J.; BANERJEE, S.; AUGUSTIN, M.; STEIN GOLD, L.; ALEXIS, A. F.; THACI, D.; LEBWOHL, M.; ISSA, N. T.; CAMERON, M. C. Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 4 Years in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 4, p. s407, 2024. DOI: 10.25251/skin.8.supp.407. Disponível em: https://jofskin.org/index.php/skin/article/view/2856. Acesso em: 23 jul. 2024.